Puma Biotechnology Inc (PBYI): Price and Financial Metrics

PBYI POWR Grades

• Value is the dimension where PBYI ranks best; there it ranks ahead of 99.33% of US stocks.
• The strongest trend for PBYI is in Stability, which has been heading up over the past 177 days.
• PBYI's current lowest rank is in the Momentum metric (where it is better than 3.78% of US stocks).

PBYI Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for PBYI is 7.57 -- better than 94.86% of US stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 8.18 for PUMA BIOTECHNOLOGY INC; that's greater than it is for 85.86% of US stocks.
• In terms of twelve month growth in earnings before interest and taxes, PUMA BIOTECHNOLOGY INC is reporting a growth rate of -148.49%; that's higher than just 9.64% of US stocks.
• Stocks that are quantitatively similar to PBYI, based on their financial statements, market capitalization, and price volatility, are CSGS, SCWX, MDRX, PLTK, and INTZ.
• PBYI's SEC filings can be seen here. And to visit PUMA BIOTECHNOLOGY INC's official web site, go to www.pumabiotechnology.com.

PBYI Valuation Summary

• PBYI's price/sales ratio is 0.6; this is 68.42% lower than that of the median Healthcare stock.
• Over the past 139 months, PBYI's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for PBYI.

PBYI Growth Metrics

The 4 year cash and equivalents growth rate now stands at -15.69%.
• Its 3 year cash and equivalents growth rate is now at 20.35%.
• Its 2 year cash and equivalents growth rate is now at -30.71%.

PBYI's revenue has moved down $54,547,000 over the prior 33 months.

The table below shows PBYI's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	217.713	-28.945	9.832
2022-06-30	206.856	-35.706	-34.48
2022-03-31	200.722	-21.906	-48.957
2021-12-31	253.155	20.65	-29.126
2021-09-30	250.355	20.45	-48.244
2021-06-30	254.864	11.672	-35.035

PBYI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• PBYI has a Quality Grade of C, ranking ahead of 66.91% of graded US stocks.
• PBYI's asset turnover comes in at 1.012 -- ranking 23rd of 682 Pharmaceutical Products stocks.
• ACAD, TVTX, and CTMX are the stocks whose asset turnover ratios are most correlated with PBYI.

The table below shows PBYI's key quality metrics over time.